Table 1.
NFLV | HF | p-value* | PostLVAD† | p-value‡ | |
---|---|---|---|---|---|
Number (n) | n=6 | n=6 | n=6 | ||
Age - yr | 40 ± 14 | 58 ± 9 | 0.03 | 59 ± 9 | 0.8 |
Sex - no. (%) | |||||
Male | 1 (17) | 6 (100) | 6 (100) | ||
Female | 5 (83) | 0 (0) | 0 (0) | ||
Race - no. (%) | |||||
White | 1 (17) | 4 (67) | 4 (67) | ||
Black | 3 (50) | 0 (0) | 0 (0) | ||
Other | 2 (33) | 2 (33) | 2 (33) | ||
Etiology - no. (%) | |||||
PHTN | 6 (100) | N/A | N/A | ||
Ischemic | N/A | 5 (83) | 5 (83) | ||
Non-Ischemic | N/A | 1 (17) | 1 (17) | ||
Echocardiography | |||||
EF (%) | 58 ± 11 | 20.6 ± 5 | <0.0001 | 30.3 ± 14.9 | 0.1 |
LVEDd (cms) | 3.6 ± 0.7 | 6.4 ± 0.5 | <0.0001 | 5.2 ± 0.9 | 0.01 |
LV size (ml) | N/A | 273 ± 67 | 187 ± 71 | 0.05 | |
Median Days on LVAD | N/A | N/A | 245.5 | ||
DM (%) | 1 (17) | 3 (50) | 3 (50) | ||
BMI (kg/m2) | 25.6 ± 4 | 30.1 ± 5 | 0.1 | 30.4 ± 5 | 0.9 |
PO2 (mmHg) | 151 ± 180 | 203 ± 158 | 0.08 | 367 ± 80 | 0.04 |
LDH (IU/L) | 820 ± 88 | 578 ± 197 | 0.009 | 726 ± 181 | 0.2 |
NFLV vs. HF,
paired samples HF-PostLVAD,
HF vs. postLVAD